IDEX Management
Management criteria checks 4/4
IDEX's CEO is Eric Ashleman, appointed in Feb 2020, has a tenure of 6.25 years. total yearly compensation is $9.11M, comprised of 11.9% salary and 88.1% bonuses, including company stock and options. directly owns 0.078% of the company’s shares, worth $12.03M. The average tenure of the management team and the board of directors is 3.2 years and 5.3 years respectively.
Key information
Eric Ashleman
Chief executive officer
US$9.1m
Total compensation
| CEO salary percentage | 11.85% |
| CEO tenure | 6.3yrs |
| CEO ownership | 0.08% |
| Management average tenure | 3.2yrs |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
Narrative Update • May 14
IEX: Dividend Strength And Buybacks Will Support Returns Going Forward
Analysts have adjusted their price target on IDEX to $237.71 from $222.71, reflecting updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News IDEX Corporation's Board of Directors approved a regular quarterly cash dividend of $0.73 per common share, scheduled to be paid on June 5, 2026, to shareholders of record on May 22, 2026.Narrative Update • Apr 26
IEX: Balanced Outlook As Buybacks And M&A Plans Will Shape Returns
Analysts now project only a slight reduction in IDEX's fair value estimate, with the updated price target moving from about $222.93 to $222.71. This reflects modest adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E.Narrative Update • Apr 12
IEX: Balanced Outlook As Buybacks And M&A Plans Shape Future Returns
Analysts have inched their price target for IDEX lower to about $223 from roughly $224, reflecting slightly revised assumptions on fair value, discount rate and forward P/E, while keeping revenue growth and profit margin expectations broadly unchanged. What's in the News IDEX completed a share repurchase tranche from October 1, 2025 to February 19, 2026, buying 632,280 shares for US$113.1 million, equal to 0.84% of shares under the existing program (Key Developments).Narrative Update • Mar 28
IEX: Ongoing Buybacks And M&A Focus Will Support Future Upside
Analysts have slightly reduced their IDEX price target to $224.29 from $225.08, citing minor model updates to fair value, discount rate, revenue growth, profit margin, and forward P/E assumptions. What's in the News IDEX completed a share repurchase program announced on April 21, 2008, buying back a total of 19,293,107 shares for US$1,623.91m, representing 24.31% of the company (Key Developments).Narrative Update • Mar 14
IEX: Ongoing M&A And Buybacks Will Support Attractive Future Upside
Analysts have raised their price target on IDEX to about $225 from roughly $224, reflecting slightly updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News IDEX is actively pursuing mergers and acquisitions, with management describing the company as about halfway through a multiyear capital deployment cycle focused on building out existing platforms and markets (Key Developments).Narrative Update • Feb 27
IEX: Future CFO And Continued M&A Will Support Steady Outlook
Analysts have kept their average IDEX price target broadly steady around $223.54, with only marginal tweaks to inputs such as the discount rate and assumed future P/E multiple to reflect updated views on the company’s risk profile and valuation framework. What's in the News IDEX is actively pursuing mergers and acquisitions, with management indicating they see themselves around the midpoint of a long term capital deployment cycle and planning additional deals to build out existing market positions, using prior acquisition activity as a reference point for future bolt on targets (Key Developments).Narrative Update • Feb 13
IEX: Future CFO Transition And Ongoing Buybacks Will Support Steady Outlook
Analysts have lifted their price target on IDEX to $223.54 from $198.62, reflecting updated assumptions that include a slightly lower discount rate and modest tweaks to revenue growth, profit margin, and future P/E expectations. What's in the News IDEX completed a share repurchase tranche between October 1, 2025 and December 31, 2025, buying 400,000 shares, or 0.53% of the company, for $75 million under its long running buyback program announced on April 21, 2008 (Key Developments).Narrative Update • Jan 30
IEX: Future CFO Transition And Capital Deployment Will Support Steady Outlook
Analysts have nudged their price target on IDEX higher to about US$199 from roughly US$197, citing updated assumptions that include a slightly lower discount rate, modest tweaks to revenue growth and profit margin expectations, and a marginally higher future P/E estimate. What's in the News IDEX appointed Sean M.Seeking Alpha • Jan 26
IDEX Corporation: Value Creator Is Not Delivering
Summary IDEX Corporation remains a mission-critical industrial solutions provider, but organic growth has stagnated, and recent performance is lackluster. Despite a long track record, IDEX's earnings have been flat near $8/share, with 2025 guidance only modestly improved, and 2026's outlook is cautious. Valuation has compressed from 30x to 24x earnings as shares fell from $235 to $195, but the premium persists without clear operating momentum. I remain cautious, as sustained improvement in organic growth and earnings is needed to justify even the reduced valuation. Read the full article on Seeking AlphaNarrative Update • Jan 15
IEX: Future CFO Appointment And Buybacks Will Support Steady Outlook
Analysts have modestly raised their fair value estimate for IDEX to US$197.08 from US$194.62, citing slightly lower assumed revenue growth and profit margins that are offset by a higher future P/E multiple and updated discount rate assumptions. What's in the News IDEX appointed Sean M.Analysis Article • Jan 07
These 4 Measures Indicate That IDEX (NYSE:IEX) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Jul 23
Why IDEX Corporation (NYSE:IEX) Could Be Worth Watching
IDEX Corporation ( NYSE:IEX ) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE...Analysis Article • Jul 01
Is IDEX (NYSE:IEX) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Jun 15
IDEX's (NYSE:IEX) Returns On Capital Not Reflecting Well On The Business
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...Seeking Alpha • Apr 27
IDEX Corporation: It's Best To Remain Cautious As Earnings Near
Summary IDEX Corporation's stock has fallen 19.3% since last July, but I still rate it a 'hold' due to its high valuation. Revenue and profitability metrics for IDEX have been volatile, with mixed results across its three main business segments. Management's 2025 guidance suggests modest revenue growth and improved earnings, but economic uncertainty and potential tariff impacts remain concerns. Awaiting Q1 2025 results on May 1st, IDEX's stock remains fairly valued compared to peers, but not attractive enough for an upgrade. Read the full article on Seeking AlphaSeeking Alpha • Feb 09
IDEX: A Wonderful Mid-Cap Focused On Long-Term Value Generation
Summary IDEX Corporation is a niche industrial manufacturer with a wide economic moat, producing mission-critical products with significant pricing power and high switching costs. Despite softer 2024 earnings, IDEX remains highly profitable with robust margins and a strong balance sheet. The firm's strategic acquisitions and entrenched customer relationships bolster its market position, ensuring continued growth and competitive insulation. Given the fair valuation and conservative fiscal management, I rate IDEX a Hold, awaiting a larger undervaluation for a potential buy. Read the full article on Seeking AlphaSeeking Alpha • Nov 06
IDEX Corporation: A Demanding Valuation For A Great Business
Summary IDEX Corporation faces sluggish organic growth and slower order intake, yet it maintains a strong long-term value proposition through mission-critical industrial and technology solutions. Despite a solid historical performance, current valuation multiples are demanding, especially given the flattish reported results. The company’s recent $1 billion acquisition of Mott is strategically aligned but comes at a high valuation, reflecting IDEX’s increased reliance on M&A for growth. Shares have risen to $235, driven by optimism, but I remain cautious due to lackluster operating performance and heightened expectations at nearly 30 times earnings. Read the full article on Seeking AlphaSeeking Alpha • Sep 02
IDEX Corp. Q2: Project Delay And Weakness In Life Science
Summary I reiterate a 'Buy' rating for IDEX, with a fair price target of $220 per share, despite near-term headwinds in organic revenue and market softness. IDEX's acquisition of Mott Corporation for $1 billion is strategically favorable, enhancing their applied material science technology and potentially improving overall margins. Project delays and market weakness, particularly in the life science sector, have led to a 4% organic revenue decline and lowered full-year growth guidance. Long-term growth prospects remain strong due to active portfolio management, strategic acquisitions, and anticipated recovery in industrial activities and life science markets by 2025. Read the full article on Seeking AlphaSeeking Alpha • Jul 11
IDEX Corp.: There Are Better Opportunities Out There
Summary IDEX Corporation's revenue grew slightly in 2024, but profitability weakened due to a drop in sales and rising costs. Management remains optimistic about organic revenue growth and adjusted net income for the year. Despite being a high-quality business, IDEX Corporation's shares are not attractively priced, making it a better 'hold' than a 'buy' prospect. Read the full article on Seeking AlphaSeeking Alpha • Jun 30
IDEX: Order Moderation Illuminating A Path Forward
Summary Order moderation in Q1 FY24 indicates initial recovery in end-markets and completion of inventory destocking. IDEX reaffirmed full-year guidance of 0%-2% organic revenue growth, anticipating end-market recovery in the second half of FY24. I predict 7% organic revenue growth from FY25 onwards, with fair value estimated at $220 per share. Read the full article on Seeking AlphaSeeking Alpha • Apr 20
Ensemble Capital - IDEX Corp: A Mundane Company Ready To Fire On All Cylinders
Summary IDEX is not well-known is because it sells decidedly mundane, typically niche parts and technology. We believe, however, that IDEX is among a class of companies that can outperform via acquisitions. IDEX has proven its ability to generate attractive returns from acquisitions in the past, and this could bode well for its chance to further compound shareholder value. Read the full article on Seeking AlphaCEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$508m |
| Dec 31 2025 | US$9m | US$1m | US$483m |
| Sep 30 2025 | n/a | n/a | US$478m |
| Jun 30 2025 | n/a | n/a | US$469m |
| Mar 31 2025 | n/a | n/a | US$479m |
| Dec 31 2024 | US$9m | US$1m | US$505m |
| Sep 30 2024 | n/a | n/a | US$490m |
| Jun 30 2024 | n/a | n/a | US$580m |
| Mar 31 2024 | n/a | n/a | US$578m |
| Dec 31 2023 | US$8m | US$992k | US$596m |
| Sep 30 2023 | n/a | n/a | US$618m |
| Jun 30 2023 | n/a | n/a | US$587m |
| Mar 31 2023 | n/a | n/a | US$587m |
| Dec 31 2022 | US$7m | US$948k | US$587m |
| Sep 30 2022 | n/a | n/a | US$576m |
| Jun 30 2022 | n/a | n/a | US$513m |
| Mar 31 2022 | n/a | n/a | US$477m |
| Dec 31 2021 | US$7m | US$900k | US$449m |
| Sep 30 2021 | n/a | n/a | US$432m |
| Jun 30 2021 | n/a | n/a | US$420m |
| Mar 31 2021 | n/a | n/a | US$389m |
| Dec 31 2020 | US$3m | US$698k | US$378m |
| Sep 30 2020 | n/a | n/a | US$374m |
| Jun 30 2020 | n/a | n/a | US$375m |
| Mar 31 2020 | n/a | n/a | US$417m |
| Dec 31 2019 | US$5m | US$620k | US$426m |
Compensation vs Market: Eric's total compensation ($USD9.11M) is below average for companies of similar size in the US market ($USD14.79M).
Compensation vs Earnings: Eric's compensation has been consistent with company performance over the past year.
CEO
Eric Ashleman (58 yo)
6.3yrs
Tenure
US$9,112,893
Compensation
Mr. Eric D. Ashleman has been Chief Executive Officer and Director of IDEX Corporation since December 15, 2020 and has been its President since February 21, 2020. He serves as a Chair at Manufacturers Alli...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 6.3yrs | US$9.11m | 0.078% $ 12.0m | |
| Senior VP | 4.3yrs | US$1.81m | 0.0059% $ 904.0k | |
| Vice President of Corporate Development | no data | US$1.76m | 0.0068% $ 1.1m | |
| Senior VP & CFO | less than a year | no data | 0.026% $ 4.0m | |
| VP & Chief Accounting Officer | 4.8yrs | US$1.40m | 0.0053% $ 823.6k | |
| Vice President of Investor Relations | 1.2yrs | no data | no data | |
| VP, Associate General Counsel & Chief Compliance Officer | 3.3yrs | no data | no data | |
| Vice President of Global Communications | no data | no data | no data | |
| VP, Chief Sustainability Officer & Associate General Counsel | no data | no data | no data | |
| VP and Chief Diversity | 3.1yrs | no data | no data | |
| Senior Vice President of Talent & Culture | less than a year | no data | no data |
3.2yrs
Average Tenure
45yo
Average Age
Experienced Management: IEX's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 5.4yrs | US$9.11m | 0.078% $ 12.0m | |
| Independent Director | 6.9yrs | US$275.26k | 0.0031% $ 472.9k | |
| Independent Director | 10.1yrs | US$280.26k | 0.0017% $ 268.9k | |
| Independent Non-Executive Chair | 10.5yrs | US$410.12k | 0.012% $ 1.9m | |
| Independent Director | 1.3yrs | US$281.54k | no data | |
| Independent Director | 8.3yrs | US$275.26k | no data | |
| Independent Director | 1.3yrs | US$281.54k | no data | |
| Independent Director | 3.9yrs | US$260.26k | 0.0010% $ 156.1k | |
| Independent Director | 5.3yrs | US$260.76k | 0.0023% $ 357.0k | |
| Independent Director | 4.3yrs | US$260.26k | 0.0023% $ 360.1k |
5.3yrs
Average Tenure
58.5yo
Average Age
Experienced Board: IEX's board of directors are considered experienced (5.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/26 19:48 |
| End of Day Share Price | 2026/05/22 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
IDEX Corporation is covered by 28 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Eade | Argus Research Company |
| Michael Halloran | Baird |
| Walter Liptak | Barrington Research Associates, Inc. |